Hot Features
Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.
Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multip... Agenus Inc is an American biotechnology company. Its main target is immuno-oncology treatments. The company's portfolio consists of therapeutic antibodies and vaccines to treat immuno-oncology illnesses: cancers, shingles, malaria, glioblastoma, and others. Agenus treatments aim, by combining multiple antibody platforms, to stimulate the immune system to recognize and fight cancer cells. The company has been cooperating with companies like Incyte, Merck Sharpe & Dohme, and Recepta Biopharma to achieve over a dozen antibody programs. Some of its products include Prophage, AutoSynVax, QS-21 Stimulon, and others. Mehr anzeigen
Presentations will showcase new data reinforcing BOT/BAL’s potential across different lines of treatment in colorectal cancer, including the neoadjuvant setting Agenus Inc. (Nasdaq: AGEN), a...
Agenus Inc., a leader in immuno-oncology, today announced further details of its strategic realignment aimed at streamlining operations, strengthening its financial position, and prioritizing the...
Agenus Inc. (“Agenus” or the “Company”) (Nasdaq: AGEN), an immuno-oncology company focused on innovation has successfully secured a $22 million non-amortizing mortgage backed by its...
| Zeitraum † | Änderung | Änderung % | Handelsbeginn | Hoch | Niedrig | Durchsch. Volumen | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0.38 | 13.9705882353 | 2.72 | 3.1 | 2.58 | 411902 | 2.743623 | CS |
| 4 | -0.35 | -10.1449275362 | 3.45 | 3.85 | 2.58 | 443144 | 2.94824051 | CS |
| 12 | -1.4 | -31.1111111111 | 4.5 | 4.91 | 2.5 | 498254 | 3.38958439 | CS |
| 26 | -13.47 | -81.2914906457 | 16.57 | 18.74 | 2.5 | 581716 | 5.71999515 | CS |
| 52 | -13.6 | -81.4371257485 | 16.7 | 19.688 | 2.5 | 3434511 | 12.2290582 | CS |
| 156 | -62.3 | -95.2599388379 | 65.4 | 69.8 | 2.5 | 4641162 | 30.54967326 | CS |
| 260 | -78.5 | -96.2009803922 | 81.6 | 135.8 | 2.5 | 4101465 | 46.93608073 | CS |
Support: +44 (0) 203 8794 460 | support@advfn.de
Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen
Premium
